US 11,857,675 B2
Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections
Guillermo Sanders Acedo, Colonia Popotia Distrito Federal (MX); Eleonora Sanders Esparza, Cuidad (MX); and Barbara Sanders Esparza, Cuidad (MX)
Assigned to Barbara Sanders Esparza, Cuidad de Mexico (MX); Eleonora Sanders Esparza, Cuidad de Mexico (MX); Gina Patricia Sanders Esparza, Cuidad de Mexico (MX); Beatriz Sanders Esparza, Cuidad de Mexico (MX); Claudia Fabiola Sanders Esparza, Cuidad de Mexico (MX); Maria Fernanda Sanders Esparza, Cuidad de Mexico (MX); Olivia Andrea Sanders Esparza, Cuidad de Mexico (MX); Guillermo Sanders Castro, Cuidad de Mexico (MX); and Eduardo Sanders Perez, Cuidad de Mexico (MX)
Filed by Eleonora Sanders Esparza, Cuidad (MX); and Barbara Sanders Esparza, Cuidad (MX)
Filed on Jul. 6, 2020, as Appl. No. 16/921,360.
Application 16/921,360 is a continuation in part of application No. 15/100,900, granted, now 10,702,470, previously published as PCT/MX2015/000121, filed on Aug. 27, 2015.
Prior Publication US 2020/0345627 A1, Nov. 5, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/34 (2006.01); A61K 9/00 (2006.01); A61F 6/14 (2006.01); A61K 33/34 (2006.01)
CPC A61K 9/0039 (2013.01) [A61F 6/144 (2013.01); A61K 33/34 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method for reducing the incidence and prevalence of the human papillomavirus types 16 and 18 in women, thus preventing the development of uterine cervical cancer in women, comprising the following steps:
providing a uterine cervical device comprising copper having a surface area between approximately 380 mm2 to approximately 524 mm2, distributed on a T-shaped frame having a horizontal arm having a length of between about 17.8 millimeters and about 32.2 millimeters, said T-shaped frame having a vertical post extending from the horizontal arm, the vertical post having a length of between about 25.8 millimeters and about 36.2 millimeters and a diameter of about 1.7 millimeters, the horizontal arm having portions on opposite sides of the vertical post and a sphere affixed to the vertical post; said T-shaped frame made of at least one member of a group comprising: polyethylene, propylene, polyester and silicone elastomer;
inserting said uterine cervical device in the lower part of the uterine cavity and endocervix,
wherein the device is maintained in position up to approximately 5 years.